ETEX Corporation, an advanced biomaterials company, announced today that the FDA has granted 510(k) clearance of CarriGen® Porous Bone Substitute Material. CarriGen is available for immediate sale through ETEX’s independent sales force.
Original post:
ETEX receives FDA marketing clearance for CarriGen Porous Bone Substitute Material (News-Medical-Net)
0 Responses to “ETEX receives FDA marketing clearance for CarriGen Porous Bone Substitute Material (News-Medical-Net)”